These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Diversity, composition, and networking of saliva microbiota distinguish the severity of COVID-19 episodes as revealed by an analysis of 16S rRNA variable V1-V3 region sequences. Larios Serrato V; Meza B; Gonzalez-Torres C; Gaytan-Cervantes J; González Ibarra J; Santacruz Tinoco CE; Anguiano Hernández YM; Martínez Miguel B; Cázarez Cortazar A; Sarquiz Martínez B; Alvarado Yaah JE; Mendoza Pérez AR; Palma Herrera JJ; García Soto LM; Chávez Rojas AI; Bravo Mateos G; Samano Marquez G; Grajales Muñiz C; Torres J mSystems; 2023 Aug; 8(4):e0106222. PubMed ID: 37310423 [TBL] [Abstract][Full Text] [Related]
5. Altered oral and gut microbiota and its association with SARS-CoV-2 viral load in COVID-19 patients during hospitalization. Wu Y; Cheng X; Jiang G; Tang H; Ming S; Tang L; Lu J; Guo C; Shan H; Huang X NPJ Biofilms Microbiomes; 2021 Jul; 7(1):61. PubMed ID: 34294722 [TBL] [Abstract][Full Text] [Related]
6. Gut bacterial dysbiosis and instability is associated with the onset of complications and mortality in COVID-19. Schult D; Reitmeier S; Koyumdzhieva P; Lahmer T; Middelhoff M; Erber J; Schneider J; Kager J; Frolova M; Horstmann J; Fricke L; Steiger K; Jesinghaus M; Janssen KP; Protzer U; Neuhaus K; Schmid RM; Haller D; Quante M Gut Microbes; 2022; 14(1):2031840. PubMed ID: 35174781 [TBL] [Abstract][Full Text] [Related]
7. The gut microbiome of COVID-19 recovered patients returns to uninfected status in a minority-dominated United States cohort. Newsome RC; Gauthier J; Hernandez MC; Abraham GE; Robinson TO; Williams HB; Sloan M; Owings A; Laird H; Christian T; Pride Y; Wilson KJ; Hasan M; Parker A; Senitko M; Glover SC; Gharaibeh RZ; Jobin C Gut Microbes; 2021; 13(1):1-15. PubMed ID: 34100340 [TBL] [Abstract][Full Text] [Related]
8. Metagenomic next-generation sequencing of nasopharyngeal microbiota in COVID-19 patients with different disease severities. Aljabr W; Dandachi I; Abbas B; Karkashan A; Al-Amari A; AlShahrani D Microbiol Spectr; 2024 May; 12(5):e0416623. PubMed ID: 38557102 [TBL] [Abstract][Full Text] [Related]
9. Sputum production and salivary microbiome in COVID-19 patients reveals oral-lung axis. Lu KY; Alqaderi H; Bin Hasan S; Alhazmi H; Alghounaim M; Devarajan S; Freire M; Altabtbaei K PLoS One; 2024; 19(7):e0300408. PubMed ID: 39052548 [TBL] [Abstract][Full Text] [Related]
11. Temporal profiles of viral load in posterior oropharyngeal saliva samples and serum antibody responses during infection by SARS-CoV-2: an observational cohort study. To KK; Tsang OT; Leung WS; Tam AR; Wu TC; Lung DC; Yip CC; Cai JP; Chan JM; Chik TS; Lau DP; Choi CY; Chen LL; Chan WM; Chan KH; Ip JD; Ng AC; Poon RW; Luo CT; Cheng VC; Chan JF; Hung IF; Chen Z; Chen H; Yuen KY Lancet Infect Dis; 2020 May; 20(5):565-574. PubMed ID: 32213337 [TBL] [Abstract][Full Text] [Related]
12. Saliva microbiome in relation to SARS-CoV-2 infection in a prospective cohort of healthy US adults. Armstrong AJS; Horton DB; Andrews T; Greenberg P; Roy J; Gennaro ML; Carson JL; Panettieri RA; Barrett ES; Blaser MJ EBioMedicine; 2023 Aug; 94():104731. PubMed ID: 37487417 [TBL] [Abstract][Full Text] [Related]
13. Limited Impact of SARS-CoV-2 on the Human Naso-Oropharyngeal Microbiota in Hospitalized Patients. Lai CKC; Cheung MK; Lui GCY; Ling L; Chan JYK; Ng RWY; Chan HC; Yeung ACM; Ho WCS; Boon SS; Chan PKS; Chen Z Microbiol Spectr; 2022 Dec; 10(6):e0219622. PubMed ID: 36350127 [TBL] [Abstract][Full Text] [Related]
14. High abundance of butyrate-producing bacteria in the naso-oropharynx of SARS-CoV-2-infected persons in an African population: implications for low disease severity. Akorli J; Opoku M; Appiah-Twum F; Akpo MS; Ismail RY; Boamah GYK; Obeng-Aboagye E; Adu-Asamoah D; Donkor IO BMC Infect Dis; 2024 Sep; 24(1):1020. PubMed ID: 39304808 [TBL] [Abstract][Full Text] [Related]
15. Dysbiosis of saliva microbiome in patients with oral lichen planus. Yu FY; Wang QQ; Li M; Cheng YH; Cheng YL; Zhou Y; Yang X; Zhang F; Ge X; Zhao B; Ren XY BMC Microbiol; 2020 Apr; 20(1):75. PubMed ID: 32245419 [TBL] [Abstract][Full Text] [Related]
16. Oral Microbiome in HIV-Infected Women: Shifts in the Abundance of Pathogenic and Beneficial Bacteria Are Associated with Aging, HIV Load, CD4 Count, and Antiretroviral Therapy. Lewy T; Hong BY; Weiser B; Burger H; Tremain A; Weinstock G; Anastos K; George MD AIDS Res Hum Retroviruses; 2019 Mar; 35(3):276-286. PubMed ID: 29808701 [TBL] [Abstract][Full Text] [Related]
19. SARS-CoV-2 Infection is Associated with Age- and Gender-Specific Changes in the Nasopharyngeal Microbiome. Bozza S; Nunzi E; Frias-Mazuecos A; Pieraccini G; Pariano M; Renga G; Mencacci A; Talesa VN; Antognelli C; Puccetti P; Romani L; Costantini C Front Biosci (Landmark Ed); 2024 Feb; 29(2):59. PubMed ID: 38420819 [TBL] [Abstract][Full Text] [Related]
20. SARS-CoV-2 does not have a strong effect on the nasopharyngeal microbial composition. Braun T; Halevi S; Hadar R; Efroni G; Glick Saar E; Keller N; Amir A; Amit S; Haberman Y Sci Rep; 2021 Apr; 11(1):8922. PubMed ID: 33903709 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]